Antihistaminic and antiallergic properties of dextro-mequitamium iodide in upper and lower guinea pig airways: Comparison with azelastine

General Pharmacology

Volumn 30, Issue 4, 1998, Pages 513-519

  Evangelista, S ^a   Boni, P ^a   Castellucci, A ^a   Perretti, F ^a   Pretolani, M ^b   Joseph, D ^b   Renzetti, A R ^c   Subissi, A ^c   Manzini, S ^d  

^a Ist Farmacobiologico Malesci SpA   (Italy)

^b U de Pharmacologie Cellulaire   (France)

^c Laboratori Guidotti SpA   (Italy)

^d Menarini Ricerche SpA   (Italy)

Author keywords

Antiallergic; Antihistamine; Azelastine; Dextro mequitamium iodide (d Meq); Plasma protein extravasation

Indexed keywords

ANTIGEN; ANTIHISTAMINIC AGENT; AZELASTINE; HISTAMINE; HISTAMINE H1 RECEPTOR; LEUKOTRIENE B4; MUSCARINIC RECEPTOR; N METHYLMEQUITAZINE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; BRONCHODILATATION; BRONCHUS; CATTLE; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; EOSINOPHILIA; GUINEA PIG; IN VITRO STUDY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT;

ANIMALS; ANTI-ALLERGIC AGENTS; BRONCHI; CAPILLARY PERMEABILITY; CATTLE; CHEMOTAXIS; EOSINOPHILS; GUINEA PIGS; HISTAMINE H1 ANTAGONISTS; INSUFFLATION; LEUKOTRIENE B4; MALE; PHENOTHIAZINES; PHTHALAZINES; PLATELET ACTIVATING FACTOR; RABBITS; RATS; VASOCONSTRICTION;

EID: 0032053442     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00296-6     Document Type: Article

References (19)

1. Abelli L., Nappi F., Subissi A., Manzini S., Giachetti A. Effect of mequitamium iodide (LG 30435) on airway microvascular leakage in the guinea pig. Pulm. Pharmac. 5:1992;137-141.
2. Baraniuk J. N. Neural control of human nasal secretion. Pulm. Pharmac. 4:1991;20-31.
3. Bellofiore S., Di Maria G. U., Martin J. G. Changes in upper and lower airways resistance after inhalation of antigen in sensitized rats. Am. Rev. Respir. Dis. 136:1987;363-368.
4. Berman B. A. Allergic rhinitis. mechanisms and management J. Allergy Clin. Immunol. 81:1988;980-984.
5. Berti F., Daffonchio L., Magni F., Omini C., Rossoni G., Subissi A. Mequitamium iodide, a new potential anti-asthmatic agent. Eur. Respir. J. 2:1989;868-873.
6. Bousquet J., Chanez P., Lacoste J. Y., Barneon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P. Eosinophilic inflammation and asthma. N. Engl. J. Med. 323:1990;1033-1039.
7. i) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmac. 22:1973;3099-3103.
8. Coëffier E., Joseph D., Vargaftig B. B. Activation of guinea pig eosinophils by human recombinant IL-5. selective priming to platelet-activating factor and interference with its antagonists J. Immunol. 147:1991;2595-2602.
9. Criscuoli M., Subissi A., Daffonchio L., Omini C. LG 30435, a new bronchodilator/antiallergic agent, inhibits Paf-acether-induced platelet aggregation and bronchoconstriction. Agents Actions. 19:1986;246-250.
10. Di Bugno C., Dapporto P., Giorgi R., Manzini S., Paoli P., Subissi A., Arcamone F. Absolute configuration and biological activity of mequitamium iodide enantiomers. Chirality. 6:1994;382-388.
11. Dorow P., Aurich R., Petzold U. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide. Arzneim. Forsch. 43:1993;909-915.
12. Howarth P. H. Allergic rhinitis. a rational choice of treatment Respir. Med. 83:1989;179-188.
13. Magnussen H. The inhibitory effect of azelastine and ketotifen on histamine-induced bronchoconstriction in asthmatic patients. Chest. 91:1987;855-858.
14. Renzetti A. R., Barone D., Criscuoli M. High affinity binding of mequitamium iodide (LG 30435) to muscarinic and histamine H1 receptors. Eur. J. Pharmac. 182:1990;413-420.
15. Richards K. L., McCullogh J. A. modified microchamber method for chemotaxis and chemokinesis. Immunol. Commun. 13:1984;49-54.
16. Subissi A., Del Monte M. Mechanisms of the antiallergic action of N-methylmequitazine (LG 30435). J. Pharm. Pharmac. 40:1988;246-250.
17. Subissi A., Criscuoli M., Renzetti A. R. LG 30435 is a new bronchodilator agent with multiple sites of action. Eur. J. Pharmac. 126:1986;81-89.
18. Tonnesen P., Hindberg I., Schaffalitzky de Muckadell O. B., Mygind N. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions. Allergy. 43:1988;310-317.
19. Vadas M. A., David J. R., Butterworth A., Pisani N. T., Siongok T. A new method for the purification of human eosinophils and neutrophils and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. Immunology. 122:1979;1228-1236.